Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$3.04
▼ $0.20 (-6.3%)
Market data updated: 09/20 06:24 AM
Fundamentals updated: 09/20/2026
News analyzed: 09/20/2026
Market Cap
$466.06M
Day Range
$3.04 - $3.32
52-Week Range
$3.04 - $14.49
Beta
—
Next Earnings
17.11.2026
Support
$3.04
Resistance
$5.43
ASPI is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-66.7% (1Y)
Strengths: 7/32 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 475.5%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: -$11.31 vs. price $3.04 (-472.1%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
38
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
4d ago · $3.19
Evidence: Panic-selling score jumped from 16 to 44 day-over-day
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
40
Quality
63
Value
38
Momentum
9
Risk
54
Sentiment
100
Fundamental
26
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **ASP Isotopes Inc.** has centered on its progress in **helium production and stable isotope expansion**, particularly highlighting the **commissioning of a liquid helium plant in South Africa** by its subsidiary, Renergen. The company also announced **evaluations of metal conversion opportunities in Namibia** and a **2026 target for deliveries**, reflecting growth in its radiopharmacy and critical materials sectors. Additionally, ASP hosted a **Capital Markets Day** and participated in investor conferences.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about ASP Isotopes Inc.. News trend score: 100. Reason: 14 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
40
🎯 Conviction (vs. Emotion)
65
Psychology
97
Fundamentals
26
Technical
9
Valuation
38
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-58%
Market Narrative
53
Fundamental Reality
65
Narrative Gap
-12
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests traders are torn between **loss aversion**—rooted in a steep 25.6% decline—and **anchoring** near resistance, while **FOMO** and **overconfidence** (from momentum vs. EPS growth) create a contradictory pull. The narrative gap (76 vs. 65) hints at optimism outpacing fundamentals, but the dominant loss aversion implies caution. The key question: *Will traders prioritize locking in gains or hold for recovery?*
Updated: 09/09/2026, 03:14 AM
What could change this?
👥 What the crowd believes
"ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth"
"Tetra4, a subsidiary of Renergen, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG)"
"Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia"
"Commenced Commissioning of Liquid Helium Plant in South Africa"
🧠 Market Brain events driving this
📈 6D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 99/100
🔴 Weakest match
Jesse Livermore — 20/100
🗣️ Why do they disagree?
The stark divide in verdicts for ASPI reflects deep methodological contrasts: Benjamin Graham’s high-scoring 'Defensive Investor' and 'Enterprising Investor' models see it as a fundamentally sound opportunity, with the former even calling it 'attractive' due to its valuation and safety margins, while Fisher and the efficient-market theorists dismiss it outright—Fisher for lacking his signature 'quality/growth' traits and the index-fund advocates for weak evidence of outperformance. Meanwhile, the middle-ground approaches like Marks and Lynch acknowledge the business’s merits but warn of overpricing or inflated expectations, mirroring Bagehot’s cautious optimism about liquidity. At the extremes, Livermore’s bearish trend-following and Veblen’s critique of speculative growth culture clash with Smith’s 'buy-and-hold' enthusiasm, illustrating how cyclicality and behavioral biases split even the most data-driven from the most contrarian perspectives.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 99
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 95
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 80
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 80
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 76
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 73
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟢 73
Deep statistical discount — a real Enterprising Investor candidate
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 73
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 62
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 57
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 56
Mixed — growth exists but the price already reflects much of it
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 48
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 48
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 31
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 21
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 20
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Based on the last 281 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 11 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
14.3%
Operating Margin
-251.2%
Net Margin
-670.2%
EBITDA Margin
-243.2%
ROE
-78.3%
ROA
-32.1%
ROIC
—
EPS
-$2.11
Cash
$285.60M
Total Debt
$14.36M
Current Ratio
12.23
Debt/Equity
0.07
How is Fair Value calculated? →
Current Price
$3.04
Estimated Fair Value (DCF)
-$11.31
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-472.1%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
25.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 25.0% | $-59.29M | $-54.40M |
| 2 | 19.4% | $-70.78M | $-59.57M |
| 3 | 13.8% | $-80.51M | $-62.17M |
| 4 | 8.1% | $-87.05M | $-61.67M |
| 5 | 2.5% | $-89.23M | $-57.99M |
Base FCF (last actual year)
$-47.43M
Terminal Value
$-1.41B
Present Value of Terminal Value
$-914.52M
Enterprise Value
$-1.21B
Net Debt
$-271.24M
Equity Value
$-939.08M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$2.46
Tangible Book Value per Share (Tangible NAV)
$2.34
Sentiment based on basic keywords (not AI) — 14 positive, 6 neutral, 0 negative out of the last 20 articles.
SeekingAlpha · 9.9.2026
Yahoo · 8.9.2026
GlobeNewswire · 8.9.2026
SeekingAlpha · 8.9.2026
Benzinga · 8.9.2026
MarketBeat · 21.8.2026
GlobeNewswire · 20.8.2026
Benzinga · 20.8.2026
GlobeNewswire · 19.8.2026
GlobeNewswire · 18.8.2026
Benzinga · 18.8.2026
Business Wire · 17.8.2026
MarketBeat · 12.8.2026
ACCESS Newswire · 7.8.2026
GlobeNewswire · 6.8.2026
Benzinga · 6.8.2026
GlobeNewswire · 5.8.2026
GlobeNewswire · 4.8.2026
GlobeNewswire · 4.8.2026
GlobeNewswire · 30.7.2026
ASP Isotopes Inc. (ASPI) currently has a StockIQ AI score of 38/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
ASPI currently scores 38/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, ASPI's estimated fair value is -$11.31, which is 472.1% below the current price of $3.04. This is one valuation model among several signals in the fair-value category, not a price target.
ASPI's technical score is 9/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 475.5%; Operating margin is stable or improving over time; Debt/equity: 0.07.
Based on the real signals StockIQ computed: Estimated fair value: -$11.31 vs. price $3.04 (-472.1%); Operating margin: -251.2% (negative); Net margin: -670.2% (negative).
StockIQ has no recorded dividend payment history for ASPI.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 16 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Kiessling Heather | Open Market Sale | 1.7.2026 | 1,526,252 | -23,124 | $6.28 |
| Wider Todd | Open Market Sale | 30.6.2026 | 672,247 | -50,000 | $6.12 |
| Gorley Michael | Open Market Sale | 30.6.2026 | 87,908 | -30,000 | $6.27 |
| Ainscow Donald George | Open Market Sale | 30.6.2026 | 800,000 | -100,000 | $6.14 |
| Wider Todd | Open Market Sale | 29.6.2026 | 722,247 | -50,000 | $6.25 |
| Ainscow Robert | Open Market Sale | 8.6.2026 | 2,281,879 | -8,438 | $7.00 |
| Mann Paul Elliot | Open Market Sale | 3.6.2026 | 9,579,845 | -83,759 | $7.76 |
| Mann Paul Elliot | Open Market Sale | 2.6.2026 | 9,663,424 | -83,758 | $8.29 |
| Mann Paul Elliot | Open Market Sale | 1.6.2026 | 9,747,182 | -83,758 | $7.88 |
| Mann Paul Elliot | Grant/Award from Employer | 28.5.2026 | 9,830,940 | +2,233,555 | — |
| Kiessling Heather | Grant/Award from Employer | 28.5.2026 | 1,549,376 | +840,000 | — |
| Ainscow Donald George | Grant/Award from Employer | 28.5.2026 | 900,000 | +400,000 | — |
| Ainscow Robert | Grant/Award from Employer | 28.5.2026 | 2,290,317 | +800,000 | — |
| Moore Duncan | Open Market Sale | 16.4.2026 | 1,044,928 | -11,642 | $5.21 |
| Ainscow Robert | Open Market Sale | 16.4.2026 | 1,490,317 | -22,500 | $5.21 |
| Kiessling Heather | Open Market Sale | 15.4.2026 | 709,376 | -23,124 | $5.48 |
| Ainscow Robert | Open Market Sale | 6.3.2026 | 1,537,817 | -8,438 | $5.44 |
| Ainscow Robert | Open Market Sale | 6.3.2026 | 1,512,817 | -25,000 | $4.51 |
| Mann Paul Elliot | Open Market Sale | 2.3.2026 | 7,597,385 | +162,153 | $5.44 |
| Wider Todd | Grant/Award from Employer | 18.12.2025 | 772,247 | +36,548 | — |
| Gorley Michael | Grant/Award from Employer | 18.12.2025 | 117,908 | +36,548 | — |
| Hunter Ralph L. JR | Grant/Award from Employer | 18.12.2025 | 47,018 | +36,548 | — |
| Ryan Robert John Andrew | Grant/Award from Employer | 18.12.2025 | 652,222 | +36,548 | — |
| Kiessling Heather | Open Market Sale | 18.12.2025 | 732,500 | -80,000 | $5.80 |
| Moore Duncan | Grant/Award from Employer | 18.12.2025 | 1,056,570 | +36,548 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
25,481,535 shares short as of 2026-08-31 · vs. 26,638,593 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
49.4% of trading volume this week was short selling, vs. 40.8% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology